Key result
Coronary plaque length ≥1.15 cm removed during CE linked to ~489% greater PMI risk.
Why the study?
Risk factors for perioperative and long-term cardiovascular events in patients undergoing CABG with adjunctive coronary endarterectomy are not well determined.
Does coronary plaque burden (plaque length-max) predict perioperative myocardial infarction in patients undergoing off-pump CABG with adjunctive coronary endarterectomy?
Cohort (n=125)
No
Does coronary plaque burden (plaque length-max) predict perioperative myocardial infarction in patients undergoing off-pump CABG with adjunctive coronary endarterectomy?
Odds Ratio: 5.89 (95% CI 1.9–18.27)
p-value: p=0.002
Coronary plaque length-max ≥1.15 cm is a strong independent predictor of perioperative myocardial infarction in patients undergoing off-pump CABG with adjunctive coronary endarterectomy.
Hypothesis-generating for plaque length-max in PMI prediction after off-pump CABG+CE; prospective validation required before clinical adoption.
Background and aims The risk factors of perioperative and long-term cardiovascular events in patients undergoing coronary artery bypass grafting (CABG) with adjunctive coronary endarterectomy (CE) are not well determined. This study evaluated the clinical value of coronary plaque burden, coronary anatomic stenosis, and serum biomarkers for predicting perioperative cardiovascular events after off-pump CABG + CE. Methods This retrospective cohort single-center study enrolled 125 patients undergoing off-pump CABG + CE between February 2018 and September 2021 in China. Coronary plaque burden was reflected by the length of plaque removed by CE. Plaque length-max, which represents the plaque length in patients undergoing single-vessel CE and the maximum plaque length in patients undergoing multivessel CE, was calculated. The primary endpoint was perioperative myocardial infraction (PMI). Results Plaque length-max was significantly higher in patients with PMI than in those without PMI (2.4 ± 1.5 vs. 1.6 ± 0.9, p = .001). A threshold plaque length-max of 1.15 cm was an independent predictor of PMI (area under the curve: 0.67; sensitivity 87.9%; specificity 59.8%; p = .005). Patients with plaque length-max ≥1.15 had a > 5-fold increase in PMI after adjusting for confounding factors (odds ratio = 5.89; p = .002). Furthermore, interleukin-6 (Beta = .32: p = .028), CD68 (Beta = .34; p = .045), and osteopontin (Beta = .43; p = .008) were significantly correlated with plaque length-max. Conclusions Plaque length-max was superior to clinical cardiovascular risk factors in predicting PMI occurrence after off-pump CABG + CE, which might be associated with systemic and plaque inflammation state.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2023) conducted a cohort in Diffuse coronary artery disease (n=125). Maximum coronary plaque length ≥1.15 cm vs. Maximum coronary plaque length <1.15 cm was evaluated on Perioperative myocardial infarction (PMI) (OR 5.89, 95% CI 1.90-18.27, p=0.002). A maximum coronary plaque length of ≥1.15 cm removed during coronary endarterectomy independently predicted a nearly 6-fold increased risk of perioperative myocardial infarction (OR 5.89).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: